These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1758824)
1. Cost considerations of analgesic therapy: an analysis of the effects of dosing frequency and route of administration. Goughnour BR Postgrad Med J; 1991; 67 Suppl 2():S87-91. PubMed ID: 1758824 [TBL] [Abstract][Full Text] [Related]
5. Patient-controlled analgesia versus intramuscular analgesic therapy. Smythe M; Loughlin K; Schad RF; Lucarroti RL Am J Hosp Pharm; 1994 Jun; 51(11):1433-40. PubMed ID: 7942878 [TBL] [Abstract][Full Text] [Related]
6. Control of severe pain with sustained-release morphine tablets v. oral morphine solution. Arkinstall WW; Goughnour BR; White JA; Stewart JH CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988 [TBL] [Abstract][Full Text] [Related]
7. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group. Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086 [TBL] [Abstract][Full Text] [Related]
8. Cost of administering controlled drugs in a hospice ward. McGettrick S; Rodgers J Health Bull (Edinb); 1996 Nov; 54(6):441-2. PubMed ID: 8990607 [TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department. Miner JR; Moore J; Gray RO; Skinner L; Biros MH Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240 [TBL] [Abstract][Full Text] [Related]
10. Cost comparison of two systems for intermittent intravenous administration of small-volume injections. Reilly RT; Strand LM; Bair JN Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678 [TBL] [Abstract][Full Text] [Related]
11. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries? Ho HS Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200 [TBL] [Abstract][Full Text] [Related]
12. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Blumenthal S; Min K; Marquardt M; Borgeat A Anesth Analg; 2007 Jul; 105(1):233-7. PubMed ID: 17578980 [TBL] [Abstract][Full Text] [Related]
13. [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?]. Schulzeck S; Gleim M; Maier C Anaesthesist; 1993 Aug; 42(8):545-56. PubMed ID: 8368476 [TBL] [Abstract][Full Text] [Related]
14. Morphine at gramme doses: kinetics, dynamics and clinical need. Smith KJ; Miller AJ; McKellar J; Court M Postgrad Med J; 1991; 67 Suppl 2():S55-9. PubMed ID: 1758817 [TBL] [Abstract][Full Text] [Related]
15. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets. Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227 [TBL] [Abstract][Full Text] [Related]
16. Potential for nonnarcotic analgesics to save personnel costs associated with controlling injectable morphine and meperidine. Koffer H; Hildebrand JR; Connell ML Am J Hosp Pharm; 1990 May; 47(5):1084-8. PubMed ID: 2337099 [TBL] [Abstract][Full Text] [Related]